ClearPoint Neuro (CLPT) EBIT Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | -37.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.56% |
| Dec 31, 2025 | -25.00% |
| Sep 30, 2025 | -2.29% |
| Jun 30, 2025 | -20.24% |
| Mar 31, 2025 | -46.18% |
| Dec 31, 2024 | -19.76% |
| Sep 30, 2024 | -5.33% |
| Jun 30, 2024 | 33.75% |
| Mar 31, 2024 | 26.19% |
| Dec 31, 2023 | -5.30% |
| Sep 30, 2023 | -29.04% |
| Jun 30, 2023 | -69.62% |
| Mar 31, 2023 | -47.83% |
| Dec 31, 2022 | -12.23% |
| Sep 30, 2022 | 0.24% |
| Jun 30, 2022 | -23.39% |
| Mar 31, 2022 | -77.17% |
| Dec 31, 2021 | -75.81% |
| Sep 30, 2021 | -199.06% |
| Jun 30, 2021 | -130.98% |
| Mar 31, 2021 | -80.40% |
| Dec 31, 2020 | -59.72% |
| Sep 30, 2020 | -39.70% |
| Jun 30, 2020 | -14.07% |
| Mar 31, 2020 | -24.35% |
| Dec 31, 2019 | -44.85% |
| Sep 30, 2019 | 24.51% |
| Jun 30, 2019 | 20.96% |
| Mar 31, 2019 | 31.87% |
| Sep 30, 2016 | 11.29% |
| Jun 30, 2016 | 23.39% |
| Mar 31, 2016 | 34.33% |
| Sep 30, 2015 | 26.40% |
| Jun 30, 2015 | -21.08% |
| Mar 31, 2015 | -234.34% |
| Dec 31, 2014 | -29.52% |
| Sep 30, 2014 | -40.68% |
| Jun 30, 2014 | -1.71% |
| Mar 31, 2014 | 260.35% |
| Dec 31, 2013 | -329.74% |
| Sep 30, 2013 | -83.00% |
| Jun 30, 2013 | -354.26% |
| Mar 31, 2013 | -18.72% |
| Dec 31, 2012 | 63.30% |
| Sep 30, 2012 | 28.91% |
| Jun 30, 2012 | 67.42% |
| Mar 31, 2012 | 32.56% |